Management of acute renal failure: New perspectives

American Journal of Kidney Diseases

Volumn 28, Issue 3, 1996, Pages 315-328

  Alkhunaizi, Ahmed M ^a   Schrier, Robert W ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Acute renal failure; dialysis; drug therapy

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANARITIDE; ATRIAL NATRIURETIC FACTOR; BIOMATERIAL; CALCIUM CHANNEL BLOCKING AGENT; CHLORPROMAZINE; CUPROPHANE; DIHYDROPYRIDINE DERIVATIVE; DILTIAZEM; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; EPIDERMAL GROWTH FACTOR; FUROSEMIDE; GALLOPAMIL; GROWTH FACTOR; NIFEDIPINE; NISOLDIPINE; NITRENDIPINE; POLY(METHYL METHACRYLATE); SCATTER FACTOR; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR ALPHA; VASOACTIVE AGENT; VERAPAMIL;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; BIOCOMPATIBILITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIALYSIS MEMBRANE; DOSE RESPONSE; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HEMOFILTRATION; HUMAN; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; KIDNEY ISCHEMIA; META ANALYSIS; MULTICENTER STUDY; NEPHROTOXICITY; NONHUMAN; OTOTOXICITY; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; REVIEW;

EID: 0029787971     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(96)90487-4     Document Type: Article

References (127)

1. Kelleher SP, Robinette JB, Conger JD: Sympathetic nervous system in the loss of autoregulation in acute renal failure. Am J Physiol 15:F379-386, 1984
2. Schrier RW, Burke TJ, Conger JD, Arnold PE: Newer aspects of acute renal failure. Proceedings of the 8th International Congress of Nephrology, Athens, Greece. Karger, June 1981, pp 63-69
3. Schrier RW, Arnold PE, Van Putten VJ, Burke TJ: Cellular calcium in ischemic acute renal failure: Role of calcium entry blockers. Kidney Int 32:313-321, 1987
4. Conger JD, Robinette JB, Schrier RW: Smooth muscle calcium and endothelium-derived relaxing factor in the abnormal vascular responses of acute renal failure. J Clin Invest 82:532-537, 1988
5. Schrier RW, Conger JD, Burke TJ: Pathogenetic role of calcium in renal cell injury, in Hatano M (ed): Nephrology. Tokyo, Japan, Springer Verlag, 1991, pp 648-659
6. Conger JD, Schultz MF, Miller F, Robinette JB: Responses to hemorrhagic arterial pressure reduction in different ischemic renal failure models. Kidney Int 46:318-323, 1994
7. Conger JD: Does hemodialysis delay recovery from acute renal failure? Semin Dial 3:146-147, 1990
8. Yeh BP, Tomki DJ, Stacy WK, Bear ES, Haden HT, Falls WF Jr: Factors influencing sodium and water excretion in uremic man. Kidney Int 7:103-110, 1975
9. Schulman G, Fogo A, Gung A, Badr K, Hakim R: Complement activation retards resolution of acute ischemic renal failure in the rat. Kidney Int 40:1069-1074, 1991
10. Schiffl H, Lang SM, Konig A, Strasser T, Haider MC, Held El: Biocompatible membranes in acute renal failure: Prospective case-controlled study. Lancet 344:570-572, 1994
11. Hakim RM, Wingard RL, Parker RA: Effect of the dialysis membranes in the treatment of patients with acute renal failure. N Engl J Med 331:1338-1347, 1994
12. st Century" meeting (NIH-sponsored), Bethesda, MD, May 6-8, 1996
13. Kierdorf H: Continuous versus intermittent treatment: Clinical results in acute renal failure. Contrib Nephrol 93:1-12, 1991
14. Mauritz W, Sporn P, Schindler I, Zadrobilek E, Roth E, Appel W: Acute renal failure in abdominal infection. Comparison of hemodialysis and continuous arteriovenous hemofiltration. Anasthesie Intensivether Notfallmed 21: 212-217, 1986
15. Rialp G, Perez-Marquez M, Betebese AJ, Snatos JA, Ballus J, Bak E, Rolgan A, Net A: Prognostic index and mortality in critically ill patients with acute renal failure treated with different dialysis techniques .Presented at the International Society of Nephrology, Madrid, Spain, July 1995
16. st Century" meeting (NIH-sponsored), Bethesda, MD, May 6-8, 1996
17. Mehta R, Farkas A, Pascual M, Fowler W: Effect of delayed consultation on outcome from acute renal failure in the ICU. J Am Soc Nephrol 6:471, 1995 (abstr)
18. DeBold AJ, Borenstein HB, Veress AT, Sonnenberg H: A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 28:89-94, 1981
19. Nakayama K, Ohkubo H, Hirose T, Inayama S, Nakanishi S: mRNA sequence of human cardiodilatin-atrial natriuretic factor precursor and regulation of precursor in RNA in rat atria. Nature 310:699-701, 1984
20. Kangawa K, Matsuo H: Purification and complete amino acid sequence of α-human atrial natriuretic polypeptide (α-hANP). Biochem Biophys Res Commun 118:131-139, 1984
21. Yamaji T, Ishibashi M, Takaku F: Atrial natriuretic factor in human blood. J Clin Invest 76:1705-1709, 1985
22. Goetz KL, Wang BC, Madwed JB, Zhu JL, Leadley RJ Jr: Cardiovascular, renal, and endocrine responses to intravenous endothelin in conscious dogs. Am J Physiol 255:R1064-1068, 1988
23. Perrella MA, Margulies KB, Wei CM, Arhus LL, Heublein DM, Burnett JC Jr: Pulmonary and urinary clearance of atrial natriuretic factor in acute congestive heart failure in dogs. J Clin Invest 87:1649-1655, 1991
24. Sonnenberg JL, Skane Y, Jeng AY, Koehn JA, Ansell JA, Wennogle LP, Ghai RD: Identification of protease 3.4.24.11 as the major atrial natriuretic factor degrading enzyme in the rat kidney. Peptides 9:173-180, 1988
25. Roy DR: Effect of synthetic ANP on renal and loop of Henle functions in the young rat. Am J Physiol 251:F220-225, 1986
26. Anand-Srivastava MB, Vinay P, Genest J, Gantin M: Effect of atrial natriuretic factor on adenylate cyclase in various nephron segments. Am J Physiol 251:F417-423, 1986
27. Huang CL, Lewicki J, Johnson LK, Cogan MG: Renal mechanism of action of rat atrial natriuretic factor. J Clin Invest 75:769-773, 1985
28. Aalkjaer C, Mulvany MJ, Nyborg NC: Atrial natriuretic factors causes specific relaxation of rat arcuate arteries. Br J Pharmacol 86:447-453, 1985
29. Veldkamp PJ, Carmines PK, Inscho EW, Navar LG: Direct evaluation of the microvascular actions of ANP in juxtamedullary nephrons. Am J Physiol 254:F440-444, 1988
30. Loutzenhiser R, Hayaski K, Epstein M: Atrial natriuretic peptide reverses afferent arterioles vasoconstriction and potentiates efferent arteriolar vasoconstriction in the isolated perfused rat kidney. J Pharmacol Exp Ther 246:522-528, 1988
31. Lanese DM, Yuan BH, Falk SA, Conger JD: Effects of atriopeptin III on isolated rat afferent and efferent arterioles. Am J Physiol 261:F1102-1109, 1991
32. Nakamoto M, Shapiro JI, Shanley PF, Chan L, Schrier RW: In vitro and in vivo protective effect of atriopeptin III on ischemic acute renal failure. J Clin Invest 80:698-705, 1987
33. Conger JD, Falk SA, Yuan BH, Schrier RW: Atrial natriuretic peptide and dopamine in a rat model of ischemic acute renal failure. Kidney Int 35:1126-1132, 1989
34. Rahman SN, Kim GE, Mathew AS, Goldberg CA, Allgren R, Schrier RW, Conger JD: Effects of atrial natriuretic peptide in clinical acute renal failure. Kidney Int 45:1731-1738, 1994
35. Allgren RL, Genter FC: A randomized, double-blind, placebo-controlled multicenter clinical trial of Anaritide atrial natriuretic peptide in the treatment of acute renal failure. Presented at the International Society of Nephrology, Satellite Symposium on Renal Failure, Barcelona, Spain, 1995, p 192
36. Malis CD, Cheung JY, Leaf A, Bonventre JV: Effects of verapamil in models of ischemic acute renal failure in the rat. Am J Physiol 245:F735-742, 1983
37. Burke TJ, Arnold PE, Gordon JA, Bulger RE, Dobyan DC, Schrier RW: Protective effect of intrarenal calcium membrane blockers before or after renal ischemia. J Clin Invest 74:1830-1841, 1984
38. Wagner K, Schultze G, Molzahn M, Neumayer HH: The influence of long-term infusion of the calcium antagonist diltiazem on postischemic acute renal failure in conscious dogs. Klin Wochenschr 64:135-140, 1986
39. Garthoff B, Hirth C, Federmann A, Kazda S, Stasch JP: Renal effects of 1,4-dihydropyridines in animal models of hypertension and renal failure. J Cardiovasc Pharmacol 9:8-13, 1987
40. Deray G, Dubois M, Beaufils H, Cacoub P, Anouar M, Jaudon MC, Baumelou A, Jouanneau C, Jacobs C: Effects of nifedipine on cisplatinum-induced nephrotoxicity in rats. Clin Nephrol 30:146-150, 1988
41. Lee SM, Michael UF: The protective effect of nitrendipine on gentamicin acute renal failure in rats. Exp Mol Pathol 43:109-114, 1985
42. Watson AJ, Gimenez LF, Klassen DK, Stout RL, Whelton A: Calcium channel blockade in experimental aminoglycoside nephrotoxicity. J Clin Pharmacol 27:625-627, 1987
43. Dobyan DC, Bulger RE: Partial protection by chlorpromazine in mercuric chloride-induced acute renal failure in rats. Lab Invest 50:578-586, 1984
44. Lumlertgul D, Wongmekiat O, Sirivanichai C, Hundagoon P, Keoplung M, Conger JD, Schrier RW: Intrarenal infusion of gallopamil in acute renal failure. A preliminary report. Drugs 42:44-50, 1991
45. Duggan KA, MacDonald GJ, Charlesworth JA, Pussel BA: Verapamil prevents post-transplant oliguric renal failure. Clin Nephrol 24:289-291, 1985
46. Wagner K, Albrecht S, Neumayer HH: Protective effect of the calcium antagonist diltiazem on acute kidney failure following kidney transplantation. The results of a prospective randomized study. Dtsch Med Wochenschr 111:1363-1367, 1986
47. Neumayer HH, Wagner K: Prevention of delayed graft function in cadaver kidney transplants by diltiazem: Outcome of two prospective, randomized clinical trials. J Cardiovasc Pharmacol 10:170-177, 1987
48. Neumayer HH, Kunzendorf U, Schreiber M: Protective effect of diltiazem and the prostacyclin analogue iloprost in human renal transplantation. Ren Fail 14:289-296, 1992
49. Neumayer HH, Kunzendorf U, Schreiber M: Protective effect of calcium antagonists in human renal transplantation. Kidney Int 41:87-93, 1992
50. Frei U, Harms A, Bakovic-Alt R, Pichlmayr R, Koch KM: Calcium channel blockers for kidney protection. J Cardiovasc Pharmacol 16:11-15, 1990
51. Tenschert W, Harfmann P, Meyer-Moldenhauer WH, Arndt R, Klosterhalfen H: Kidney protective effect of diltiazem after renal transplantation with long cold ischemia time and triple-drug immunosuppression. Transplant Proc 23:1334-1335, 1991
52. Dawidson I, Rooth P, Lu C, Sagalowsky A, Diller K, Palmer B, Peters P, Risser R, Sandor Z, Seney F: Verapamil improves the outcome after cadaver renal transplantation. J Am Soc Nephrol 2:983-990, 1991
53. Alcaraz A, Oppenheimer F, Talbot-Wreight R, Fernandez-Cruz L, Manalich M, Garcia-Pages E, Cetina A, Vendrell JR, Carretero P: Effect of diltiazem in the prevention of acute tubular necrosis, acute rejection, and cyclosporine levels. Transplant Proc 23:2383-2384, 1991
54. Oppenheimer F, Alcaraz A, Manalch M, Ricart MJ, Vilardell J, Campistol JM, Andreu J, Talbot-Wright R, Fernandez-Cruz L: Influence of the calcium blocker diltiazem on the prevention of acute renal failure after renal transplantation. Transplant Proc 24:50-51, 1992
55. Donnelly PK, Feehally J, Jurewicz A, Furness P, McCullough T, Harper SJ, Moorhouse J, Morgan J, Kehinde EO, Horsburgh T: Renal transplantation: Nifedipine for the nonstarters? A prospective randomized study. Transplant Proc 25:600-601, 1993
56. Barenbrock M, Colmorgen U, Firschka E, Gellert J, Lippert J, Schröder K, Spieker C, Voigt-Ladner G, Wagner K, Neumayer HH, Rahn H: A multicenter, randomized, double-blind, placebo-controlled, two-year trial to study the effect of nitrendipine on chronic renal transplant function. Clin Nephrol 43:388-391, 1995
57. Neumayer HH, Junge W, Kufner A, Wenning A: Prevention of radiocontrast-media induced nephrotoxicity by the calcium channel blocker nitrendipine: A prospective randomized clinical trial. Nephrol Dial Transplant 4:1030-1036, 1989
58. Cacoub P, Deray G, Baumelou A, Jacobs C: No evidence for protective effects of nifedipine against radiocontrast-induced acute renal failure. Clin Nephrol 29:215-216, 1988
59. Schwartz LB, Gewertz BL: The renal response to low dose dopamine. J Surg Res 45:574-588, 1988
60. Duke GJ, Bersten AD: Dopamine and renal salvage in the critically ill patient. Anaesth Intensive Care 20:277-302, 1992
61. Seri I, Kone BC, Gullans SR, Aperia A, Brenner BM, Ballermann BJ: Locally formed dopamine inhibits Na-K-ATPase activity in rat renal cortical tubule cells. Am J Physiol 255:F666-673, 1988
62. Chintala MS, Lokhandwala MF, Jandhyala BS: Protective effects of dopexamine hydrochloride in renal failure after acute haemorrhage in anaesthetized dogs. J Auton Pharmacol 10:95-102, 1990
63. Conger JD, Falk SA, Hammond WS: Atrial natriuretic peptide and dopamine in established acute renal failure in the rat. Kidney Int 40:21-28, 1991
64. Lindner A: Synergism of dopamine and furosemide in diuretic resistant, oliguric acute renal failure. Nephron 33:121-126, 1983
65. Graziani G, Casati S, Cantaluppi A, Citterio A, Aroldi A, Scalamogna A, Brancaccio D, Ponticelli C: Dopamine-furosemide therapy in acute renal failure. Proc EDTA 19:319-324, 1983
66. Lumlertgul D, Keopling M, Sitprija V, Moollaor P, Suwangool P: Furosemide and dopamine in malarial acute renal failure. Nephron 52:40-44, 1989
67. Weisberg LS, Kurnik PS, Kurnik BR: Dopamine and renal blood flow in radiocontrast induced nephropathy in humans. Ren Fail 15:61-68, 1993
68. Flancbaum L, Choban PS, Dasta JF: Quantitative effects of low-dose dopamine on urine output in oliguric surgical intensive care unit patients. Crit Care Med 22:61-65, 1994
69. Duke GJ, Briedis JH, Weaver RA: Renal support in critically ill patients: Low-dose dopamine or low-dose dobutamine? Crit Care Med 22:1919-1925, 1994
70. Myles PS, Buckland MR, Schenk NJ, Cannon GB, Langley M, Davis BB, Weeks AM: Effect of "renal-dose" dopamine on renal function following cardiac surgery. Anaesth Intensive Care 21:56-61, 1993
71. Wagner K, Daul A: Prevention of acute renal failure. Med Klin 88:251-255, 1993
72. Baldwin L, Henderson A, Hickman P: Effect of post-operative low-dose dopamine on renal function after elective major vascular surgery. Ann Intern Med 120:744-747, 1994
73. Anderson RJ, Schrier RW: Acute tubular necrosis, in Schrier RW, Gottschalk CW (eds): Diseases of the Kidney. Boston, MA, Little, Brown, 1993, pp 1287-1318
74. Bacallao R, Fine LG: Molecular events in the organization of renal tubular epithelium: From nephrogenesis to regeneration. Am J Physiol 257:F913-924, 1989
75. Toback FG: Regeneration after acute tubular necrosis. Kidney Int 41:226-246, 1992
76. Fine LG, Norman JT: Renal growth responses to acute and chronic injury: Routes to therapeutic intervention. J Am Soc Nephrol 2:5206-5211, 1992
77. Fine LG, Hammernan MR, Abboud HE: Evolving role of growth factors in the renal response to acute and chronic disease. J Am Soc Nephrol 2:1163-1170, 1992
78. Humes HD, Cieslinski DA: Interaction between growth factors and retinoic acid in the induction of kidney tubulogenesis in tissue culture. Exp Cell Res 201:8-15, 1992
79. Breyer MD, Redha R, Breyer JA: Segmental distribution of epidermal growth factor binding sites in rabbit nephron. Am J Physiol 259:F553-558, 1989
80. Arnquist HJ, Ballermann BJ, King GL: Receptors for and effect of insulin and IGF-I in rat glomerular mesangial cells. Am J Physiol 254:C411-416, 1988
81. Hammerman MR, Miller SB: Therapeutic use of growth factors in renal failure. J Am Soc Nephrol 5:1-11, 1994
82. Fisher DA, Salido EC, Barajase L: Epidermal growth factor and the kidney. Annu Rev Physiol 51:67-80, 1989
83. Humes HD, Cieslinski DA, Coimbra TM, Messana JM, Glavao C: Epidermal growth factor enhances renal tubule cell regeneration and repair and accelerates the recovery of renal function in postischemic acute renal failure. J Clin Invest 84:1757-1761, 1989
84. Coimbra T, Cieslinski DA, Humes HD: Exogenous epidermal growth factor enhances renal repair in mercuric chloride-induced acute renal failure. Am J Physiol 259:F438-443, 1990
85. Humes HD, Shigang L: Cellular and molecular basis of renal repair in acute renal failure. J Lab Clin Med 124:749-754, 1994
86. Safirstein R, Price PM, Saggi SJ, Harris RC: Changes in gene expression after temporary renal ischemia. Kidney Int 37:1515-1521, 1990
87. Behrens MT, Corbin AL, Hise MK: Epidermal growth factor receptor regulation in rat kidney: Two models of renal growth. Am J Physiol 257:F1059-1064, 1989
88. Schaudies RP, Johnson JP: Multiple EGF containing proteins in rat kidney: Increased soluble EGF following ischemia is accompanied by a decrease in membrane-associated EGF. Am J Physiol 264:F523-531, 1993
89. Van Den Brande JL: Structure of the human insulin-like growth factors: Relationship to function, in Schofield PN (ed): The Insulin-Like Growth Factors: Structure and Biological Functions. Oxford, UK, Oxford University Press, 1992, pp 12-44
90. Rogers SA, Ryan G, Hammerman MR: Insulin-like growth factors I and II are produced in the nephrones and are required for growth and development in vitro. J Cell Biol 113:1447-1453, 1991
91. Humes HD, Beals TE, Cieslinski DA, Sanchez IO, Page TP: Effect of transforming growth factor-beta, transforming growth factor-alpha, and other growth factors on renal proximal tubule cells. Lab Invest 64:538-545, 1991
92. Moxham C, Jacobs S: Insulin-like growth factors, in Schofield PN (ed): The Insulin-Like Growth Factors: Structure and Biological Functions. Oxford, UK, Oxford University Press, 1992, pp 80-109
93. Matejka GL, Jennische E: IGF-I binding and IGF-I expression in the post-ischemic regenerating rat kidney. Kidney Int 42:1113-1123, 1992
94. Miller SB, Martin DR, Kissane J, Hammerman MR: Insulin like growth factor I accelerates recovery from ischemic acute tubular necrosis in the rat. Proc Natl Acad Sci USA 89:11876-11880, 1992
95. st Century" meeting (NIH-sponsored), Bethesda, MD, May 6-8, 1996
96. Nakamura T, Nawa K, Ishihara A: Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 122:1450-1459, 1984
97. Igawa T, Kanda S, Kanetake H, Saitoh Y, Ichihara A, Tomita Y, Nakamura T: Hepatocyte growth factor is a potent mitogen for cultured rabbit renal epithelial cells. Biochem Biophys Res Commun 174:831-838, 1991
98. Igawa T, Matsumoto K, Kanda S, Saito Y, Nakamura T: Hepatocyte growth factor may function as a renotropic factor for regeneration in rats with acutely induced renal injury. Am J Physiol 265:F61-69, 1993
99. Miller SB, Martin DR, Kissane J, Hammerman MR: Hepatocyte growth factor accelerates recovery from acute ischemic renal injury in rat. Am J Physiol 266:F129-134, 1994
100. Mehta RL: Therapeutic alternatives to renal replacement for critically ill patients in acute renal failure. Semin Nephrol 14:64-82, 1994
101. Routh GS, Briggs JD, Mone JG, Ledingham IM: Survival from acute renal failure with and without multiple organ dysfunction. Postgrad Med J 56:244-247, 1980
102. Gornick CC, Kjellstrand CM: Acute renal failure complicating aortic aneurysm surgery. Nephron 35:145-157, 1983
103. Cioffi WG, Ashikage T, Gamelli RL: Probability of surviving postoperative acute renal failure: Development of a prognostic index. Ann Surg 200:205-211, 1984
104. Lien J, Chan V: Risk factors influencing survival in acute renal failure treated by hemodialysis. Arch Intern Med 145:2067-2069, 1985
105. Cameron JS: Acute renal failure in the intensive care unit today. Intensive Care Med 12:64-70, 1986
106. Lange HW, Heppli DM, Brown DC: Survival of patients with acute renal failure requiring dialysis after open heart surgery: Early prognostic indicators. Am Heart J 113:1138-1143, 1987
107. Dobkin JE, Cutler RE: Use of APACHE II classification to evaluate outcome of patients receiving hemodialysis in an intensive care unit. West J Med 149:547-550, 1988
108. Lohr JW, McFarlane MJ, Grantham JJ: A clinical index to predict survival in acute renal failure patients requiring dialysis. Am J Kidney Dis 3:254-259, 1988
109. Maher ER, Robinson KN, Scoble JE, Farrimond JG, Browne DR, Sweny P, Moorhead JF: Prognosis of critically-ill patients with acute renal failure: APACHE II score and other predictive factors. Q J Med 72:857-866, 1989
110. Liano F, Garcia-Martin F, Gallego A, Orte L, Teruel JL, Marcen R, Matesanz R, Ortuno J: Easy and early prognosis in acute tubular necrosis: A forward analysis of 228 cases. Nephron 51:307-313, 1989
111. Guly UM, Turney JH: Post traumatic acute renal failure 1956-1988. Clin Nephrol 34:79-83, 1990
112. McCauley J, Van Thiel DH, Starzl TE, Puschett JB: Acute and chronic renal failure in liver transplantation. Nephron 55:121-128, 1990
113. Schaefer JH, Jochimsen F, Keller F, Wegscheider K, Distler A: Outcome prediction of acute renal failure in medical intensive care. Intensive Care Med 17:19-24, 1991
114. Biesenbach G, Zazgornik J, Kaiser W, Grafinger P, Stuby U, Necek S: Improvement of prognosis in patients with acute renal failure over a period of 15 years. An analysis of 710 cases in dialysis centers. Am J Nephrol 12:319-325, 1992
115. Schneider NS, Geronemus RP: Continuous arteriovenous hemodialysis. Kidney Int 5:159-162, 1988
116. Gibney RTN, Stollery DE, Lefebvre RE, Sharum CJ, Chan P: Continuous arteriovenous hemodialysis: An alternative therapy for acute renal failure associated with critical illness. Can Med Assoc J 139:861-866, 1988
117. Stevens PE, Riley B, Davies SP, Gower PE, Brown EA, Kox W: Continuous arteriovenous hemodialysis in critically ill patients. Lancet 2:150-152, 1988
118. Keller E, Reetze-Bonorden P, Bohler J, Schollmeyer P: Continuous arteriovenous hemodialysis (CAVHD): Experience in 26 intensive care patients. Contrib Nephrol 93:47-50, 1991
119. Schafer GE, Doring C, Sodemann K, Russ A, Schroder HM: Continuous arterio-venous and veno-venous hemodialysis in critically ill patients. Contrib Nephrol 93:23-28, 1991
120. McDonald BR, Mehta RL, Ward DM: Decreased mortality in patients with acute renal failure (ARF) undergoing continuous arteriovenous hemodialysis (CAVHD) in the intensive care unit (ICU). Contrib Nephrol 93:51-56, 1991
121. Bastien O, Saroul C, Hercule C, George M, Estanove S: Continuous venovenous hemodialysis after cardiac surgery. Contrib Nephrol 93:76-78, 1991
122. Geronemus RP, Schneider NS, Epstein M: Survival in patients treated with continuous arteriovenous hemodialysis (CAVHD) for acute renal failure (ARE) and chronic renal failure (CRF). Contrib Nephrol 93:29-31, 1991
123. Bellomo R, Parkin G, Love J, Boyce N: Use of continuous hemodiafiltration: An approach to the management of acute renal failure in the critically ill. Am J Nephrol 12:240-245, 1992
124. Spiegel DM, Ullion ME, Zerbe GO, Berl T: Determinants of survival and recovery in acute renal failure patients dialyzed in intensive care units. Am J Nephrol 11:44-47, 1991
125. Appel GB: Aminoglycoside nephrotoxicity. Am J Med 88:16S-20S, 1990
126. Hatala R, Dinh T, Cook DJ: Once-daily aminoglycoside dosing in immunocompetent adults: A meta-analysis. Ann Intern Med 124:717-725, 1996
127. Conger JD: Interventions in clinical acute renal failure: What are the data? Am J Kidney Dis 26:565-576, 1995